Action of cannabidiol on the anxiety and other effects produced by δ9-THC in normal subjects

Psychopharmacology
1982
A. W. Zuardi, I. Shirakawa, E. Finkelfarb, & I. G. Karniol

Please use this link to access this publication: https://link.springer.com/article/10.1007/BF00432554

Abstract

The object of the experiment was to verify whether cannabidiol (CBD) reduces the anxiety provoked by Δ 9-TCH in normal volunteers, and whether this effect occurs by a general block of the action of Δ 9-TCH or by a specific anxiolytic effect. Appropriate measurements and scales were utilized and the eight volunteers received, the following treatments in a double-blind procedure: 0.5 mg/kg Δ 9-TCH, 1 mg/kg CBD, a mixture containing 0.5 mg/kg Δ 9-TCH and 1 mg/kg CBD and placebo and diazepam (10 mg) as controls. Each volunteer received the treatments in a different sequence. It was verified that CBD blocks the anxiety provoked by Δ 9-TCH, however this effect also extended to marihuanalike effects and to other subjective alterations induced by Δ 9-TCH. This antagonism does not appear to be caused by a general block of Δ 9-TCH effects, since no change was detected in the pulse-rate measurements. Several further effects were observed typical of CBD and of an opposite nature to those of Δ 9-TCH.

These results suggest that the effects of CBD, as opposed to those of Δ 9-TCH, might be involved in the antagonism of effects between the two cannabinoids.

This library aims to empower you with knowledge but it does not replace the personalized advice and guidance a healthcare professional can provide. Before implementing any changes to your health regimen based on the contents of this library, we strongly advise you to consult with a qualified healthcare professional. Your doctor’s expertise is essential for interpreting how these insights may apply to your unique health circumstances.